Appointments

866.320.4573

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Davendra Sohal, MD, MPH

216.444.8258

Davendra Sohal, MD, MPH
Department: Hematology and Oncology
Associate Staff
Location: Cleveland Clinic Main Campus
Mail Code R35
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.8258
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Davendra Sohal, MD, MPH, is an oncologist at Cleveland Clinic Taussig Cancer Institute. Clinically, his primary interest is caring for patients with gastrointestinal malignancies, including clinical trials of new treatments for these patients.

Dr. Sohal earned his medical degree from the All India Institute of Medical Sciences in New Delhi, India.He completed residency training and a year as a Chief Resident in Internal Medicine at the Jacobi Medical Center of the Albert Einstein College of Medicine in Bronx, NY. Dr. Sohal completed a fellowship in Hematology/Oncology at the University of Pennsylvania in Philadelphia, PA.

Dr. Sohal has also completed graduate training in epidemiology and biostatistics at the University of Alabama at Birmingham. He has published several articles in peer-reviewed journals and presented at various international meetings. In addition to teaching awards, Dr. Sohal received an American Society of Hematology (ASH) Trainee Research Award and an American Society of Clinical Oncology (ASCO) Young Investigator Award.

Education & Fellowships

Fellowship - University of Pennsylvania / Pennsylvania Hospital
Hematology/Oncology
Philadelphia, PA USA
2012
Residency - Jacobi Medical Center, Albert Einstein College of Medicine
Internal Medicine
Bronx, NY
2009
Graduate - University of Alabama at Birmingham
Birmingham, AL USA
2005
Medical School - All India Institute of Medical Sciences
New Delhi India
2002

Certifications

  • Internal Medicine
  • Internal Medicine- Medical Oncology

Treatment & Services

  • Clinical Trials
  • Experimental Therapeutics

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 1/31/2014, Dr. Sohal has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
  • Hindi
  • Panjabi